Suchergebnis | Hamburg Open Science

Facetten

22 Einträge gefunden

Pretreatment tables predicting pathologic stage of locally advanced prostate cancer
2015 - Forschungsinformationssystem des UKE
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study
2015 - Forschungsinformationssystem des UKE
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.
2012 - Forschungsinformationssystem des UKE
Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
2012 - Forschungsinformationssystem des UKE
The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysis.
2012 - Forschungsinformationssystem des UKE
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level
2008 - Forschungsinformationssystem des UKE
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
2008 - Forschungsinformationssystem des UKE
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
2008 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
2007 - Forschungsinformationssystem des UKE
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
2007 - Forschungsinformationssystem des UKE
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
2007 - Forschungsinformationssystem des UKE
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
2007 - Forschungsinformationssystem des UKE
Prostate volume and adverse prostate cancer features: fact not artifact.
2007 - Forschungsinformationssystem des UKE
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
2007 - Forschungsinformationssystem des UKE
Development and external validation of an extended 10-core biopsy nomogram.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Pretreatment tables predicting pathologic stage of locally advanced prostate cancer

Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study

Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.

Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.

The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysis.

Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.

A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.

Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.

Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.

Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.

Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.

Prostate volume and adverse prostate cancer features: fact not artifact.

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.

Development and external validation of an extended 10-core biopsy nomogram.